Abstract
A set of ruthenium complexes of +3 oxidation state were synthesized with the available ruthenium precursors and the synthesized Schiff base ligands. The complexes are formed by the substitution of the ligand in the octahedral metal precursors. Samples are characterized using analytical as well as spectroscopic techniques. To ascertain pharmacological properties binding study with DNA were carried out. Further, cleavage studies were performed with gel electrophoresis. The in vitro antitumor property was analysed in HeLa tumor cell lines.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
